Mentor:  Dr. Joanne E. Murphy-Ullrich, Professor of Pathology, Co-Director, BioMatrix Engineering and Regenerative Medicine Center, VH G001, 1720 2nd Avenue South, Birmingham, AL 35294-0019, Email: murphy@uab.edu

A Postdoctoral position is available in the laboratory of Joanne Murphy-Ullrich, Ph.D., in the Department of Pathology at the Alabama at Birmingham. Our research examines the role of the endoplasmic reticulum stress protein calreticulin in regulating TGF-beta signaling and fibrosis through control of calcium-dependent signaling. This position is funded by a new grant to study the role of calreticulin in TGF-beta signaling in the kidney proximal tubule under diabetic conditions. The applicant will be expected to examine in vitro mechanisms of calreticulin-TGF-beta regulation under high glucose and oxidant conditions and also to perform in vivo studies using several novel mouse models of diabetic nephropathy.

Candidates must have a recent Ph.D. and/or M.D., or equivalent. Priority will be given to qualified candidates with a strong background in cell culture, molecular biology, biochemistry, animal models, and diabetes-related research. The candidate will be expected to write manuscripts and present his/her work at scientific meetings and assist with training of graduate level personnel in the lab. Salary (with benefits) will follow NIH guidelines commensurate with training and experience. Competitive applicants should have a proven track record with publications and the potential for career development. UAB is a highly collegial and interactive environment that has an active Office of Post-doctoral Education which provides mentoring and career guidance in addition to that provided by the mentor.

If interested, please send a letter describing your research experience/interest/future career goals, your CV, and contact information for three references electronically to murphy@uab.edu.

Postdocs in UAB News

More Items

UAB Research News

  • Blocking specific neuron interaction may slow Parkinson's progression
    Two experimental drugs that block LRRK2 kinase enzyme were shown to lessen aggregations of alpha synuclein protein, which have been shown to play a role in the development of Parkinson's disease, report researchers at the University of Alabama Birmingham.
  • UAB optometrist improves treatment and care for patients with dry eye
    Kelly Nichols, O.D., Ph.D., a dry eye expert and dean of the University of Alabama at Birmingham School of Optometry, conducted research studies for the parent drug company to explore the efficacy and safety of lifitegrast in treating this eye condition that affects more than 16 million adults in the United States.
More Items